Journal
ACS NANO
Volume 7, Issue 2, Pages 889-902Publisher
AMER CHEMICAL SOC
DOI: 10.1021/nn3052082
Keywords
vault; nanoparticle; drug delivery; vaccine; adjuvant; immunotherapy; major vault protein (MVP); INT (MVP interaction domain)
Categories
Funding
- Jonsson Comprehensive Cancer Center at UCLA
Ask authors/readers for more resources
Vaults are naturally occurring nanoparticles found widely in eukaryotes. The particles can be produced in large quantities and are assembled in situ from multiple copies of the single structural protein following expression. Using molecular engineering, recombinant vaults can be functionally modified and targeted, and their contents can be controlled by packaging. Here, we review the development of engineered vaults as a platform for a wide variety of therapeutic applications and we examine future directions for this unique nanoparticle system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available